|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Items not requiring (providing) cash: | |||||
| Depreciation and amortization | |||||
| Provision for (reversal of) credit loss expense - loans | |||||
| Gain on sale of available-for-sale securities | |||||
| Provision for (reversal of) credit loss expense - off balance sheet | |||||
| Amortization of premiums and discounts on securities-net | |||||
| Amortization of intangible assets | |||||
| Deferred income taxes | |||||
| Originations of loans held for sale | |||||
| Proceeds from sale of loans held for sale | |||||
| Net gains on sales of loans | |||||
| Expense related to share-based compensation plans | |||||
| Realized (gain) loss on sale of available-for-sale securities | |||||
| Net loss (gain) or on sale or write-down of foreclosed assets and other repossessed assets | |||||
| Increase in cash surrender value of bank-owned life insurance | |||||
| Amortization of debt issuance costs | |||||
| Changes in: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Purchases of available-for-sale securities | |||||
| Sales of available-for-sale securities | |||||
| Maturities, prepayments and calls | |||||
| Net change in loans | |||||
| Purchase of Federal Home Loan Bank Stock | |||||
| Redemption of Federal Home Loan Bank Stock | |||||
| Purchase of bank-owned life insurance | |||||
| Purchases of premises and equipment, net | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from sales of foreclosed assets | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Net increase (decrease) in deposits | |||||
| Net change in securities sold under repurchase agreements | |||||
| Repurchase of common stock | |||||
| Finance lease payments | |||||
| Proceeds from Federal Home Loan Bank Advances | |||||
| Cash dividends paid | |||||
| Net cash provided (used in) by financing activities | |||||
| Increase (Decrease) in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents, Beginning of Year | |||||
| Cash and Cash Equivalents, End of Year | |||||
| Supplemental Cash Flows Information | |||||
| Interest paid on deposits and borrowings | |||||
| Federal income taxes paid | |||||
| Supplemental Disclosure of Non-Cash Investing Activities | |||||
| Transfers from loans to foreclosed assets held for sale | |||||
| Adoption of ASU 2016-13 | |||||
| Finance lease asset and liability | |||||
Loading...